Nomura, Masaki

Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility

Xu, H., Wang, B., Ono, M., Kagita, A., Fujii, K., Sasakawa, N., Ueda, T., Gee, P., Nishikawa, M., Nomura, M., et al. (2019) · Cell stem cell

Pluripotent Stem Cells ResearchCRISPR and Genetic Engineering

Cited by 581

Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson’s disease

Doi, D., Magotani, H., Kikuchi, T., Ikeda, M., Hiramatsu, S., Yoshida, K., Amano, N., Nomura, M., Umekage, M., Morizane, A., et al. (2020) · Nature Communications

Pluripotent Stem Cells ResearchParkinson's Disease Mechanisms and Treatments

Cited by 350

Epigenetic variation between human induced pluripotent stem cell lines is an indicator of differentiation capacity

Nishizawa, M., Chonabayashi, K., Nomura, M., Tanaka, A., Nakamura, M., Inagaki, A., Nishikawa, M., Takei, I., Oishi, A., Tanabe, K., et al. (2016) · Cell stem cell

Pluripotent Stem Cells ResearchEpigenetics and DNA Methylation

Cited by 234

HLA-Matched Allogeneic iPS Cells-Derived RPE Transplantation for Macular Degeneration

Sugita, S., Mandai, M., Hirami, Y., Takagi, S., Maeda, T., Fujihara, M., Matsuzaki, M., Yamamoto, M., Iseki, K., Hayashi, N., et al. (2020) · Journal of Clinical Medicine

Retinal Development and DisordersRetinal Diseases and Treatments

Cited by 190

The Diversity of Cortical Inhibitory Synapses

Kubota, Y., Karube, F., Nomura, M., & Kawaguchi, Y. (2016) · Frontiers in Neural Circuits

Neuroscience and Neuropharmacology ResearchNeural dynamics and brain function

Cited by 180

MYC Releases Early Reprogrammed Human Cells from Proliferation Pause via Retinoblastoma Protein Inhibition

Rand, T. A., Sutou, K., Tanabe, K., Jeong, D., Nomura, M., Kitaoka, F., Tomoda, E., Narita, M., Nakamura, M., Nakamura, M., et al. (2018) · Cell Reports

Pluripotent Stem Cells ResearchDevelopmental Biology and Gene Regulation

Cited by 37